Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2005
07/12/2005US6916476 Keyhole limpet hemocyanin (klh); anticancer agents; treating melanoma
07/12/2005US6916471 Amplification of nitroso compouds in erythrocytes; obtain mammal, inject with therapeutic agent, monitor concentration levels of preferential nitroso compounds
07/12/2005US6916470 Methods for use of mpl ligands with primitive human stem cells
07/12/2005US6916303 Photoreduction method for hemoglobin-vesicle
07/12/2005US6915802 Medicament pack
07/12/2005CA2351429C 13-membered azalides and their use as antibiotic agents
07/12/2005CA2349142C Compositions and methods for stimulating gastrointestinal motility
07/12/2005CA2341739C Quinolin-2-one derivatives useful as anticancer agents
07/12/2005CA2323008C Pharmaceutically active compounds
07/12/2005CA2319542C The treatment of sexual dysfunction in certain patient groups
07/12/2005CA2303309C Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
07/12/2005CA2298142C Soya extract, process for its preparation and pharmaceutical composition
07/12/2005CA2283518C Diagnostic agents for pancreatic exocrine function
07/12/2005CA2244912C Novel substituted cyclic amino acids as pharmaceutical agents
07/12/2005CA2230947C Implantable controlled release device to deliver drugs directly to an internal portion of the body
07/12/2005CA2195370C A method of separating the racemate of tramadol
07/12/2005CA2175054C 2-(pyrazol-3-yl)carbapenem derivatives
07/12/2005CA2160798C Gaba-ergic modulation of eye growth
07/12/2005CA2137525C Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
07/12/2005CA2105867C Novel imidazole derivatives, their preparation and therapeutic applications
07/12/2005CA2094335C 4,1-benzoxazepin derivatives and their use
07/09/2005CA2455018A1 Process for the preparation of piperidine derivatives
07/07/2005WO2005061684A1 Fat composition
07/07/2005WO2005061551A1 Carboxy-reduced derivatives of chondroitin sulphate, method of preparing said derivatives, application thereof as a medicament and pharmaceutical compositions containing same
07/07/2005WO2005061550A1 Carboxy-reduced derivatives of hyaluronic acid, method of preparing said derivatives, application thereof as a medicament and pharmaceutical compositions containing same
07/07/2005WO2005061549A1 Carboxy-reduced derivatives of dermatan sulphate, method of preparing said derivatives, application thereof as a medicament and pharmaceutical compositions containing same
07/07/2005WO2005061548A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins.
07/07/2005WO2005061523A1 Glycosaminoglycan (gag) mimetics
07/07/2005WO2005061519A1 Kinase inhibitors
07/07/2005WO2005061518A1 Mitotic kinesin inhibitors
07/07/2005WO2005061516A1 Novel chemical compounds
07/07/2005WO2005061513A1 Polycyclic agents for the treatment of respiratory syncytial virus infections
07/07/2005WO2005061507A1 Bicyclic pyrazol-4-one cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061506A1 Bicyclic pyrazolyl and imidazolyl compounds as cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061505A1 Bicyclic imidazolyl pyrimidin-4-one cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061504A1 Bicyclic pyridazinone cannabinoid receptor ligands and uses thereof
07/07/2005WO2005061499A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity
07/07/2005WO2005061498A1 Substituted 1h-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase i epsilon
07/07/2005WO2005061497A1 Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
07/07/2005WO2005061495A1 Nicotinic acetylcholine receptor ligands
07/07/2005WO2005061494A1 Nicotinic acetylcholine receptor ligands
07/07/2005WO2005061493A2 Polymorphic form b2 of ziprasidone base
07/07/2005WO2005061492A1 Nitrogen-containing heterocyclic compounds and drugs comprising the same as the active ingredient
07/07/2005WO2005061491A2 Aralkyl and aralkylidene heterocyclic lactams with affinity for 5-ht1 receptors
07/07/2005WO2005061487A1 Hiv protease inhibiting compounds
07/07/2005WO2005061486A1 Crystalline form of 2-{4-‘3-(4-chloro-2-fluorophenyl)-4-pyrimidin-4-yl-1h-pyrazol-5-yl!piperidin-1-yl}-2-oxoethanol
07/07/2005WO2005061485A1 Process for making substituted pyrazoles
07/07/2005WO2005061484A1 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof
07/07/2005WO2005061483A2 Modulators of peripheral 5-ht receptors
07/07/2005WO2005061476A2 Aroylfuranes and aroylthiophenes
07/07/2005WO2005061470A1 1-akan-2-ol substituted piperazine and piperidine compounds
07/07/2005WO2005061468A1 Halogenated biaryl heterocyclic compounds and methods of making and using the same
07/07/2005WO2005061467A2 Piperazine derivatives as bradykinin antagonists
07/07/2005WO2005061466A1 Novel phenylalanine derivative
07/07/2005WO2005061463A1 Pyrazole derivatives as protein kinase modulators
07/07/2005WO2005061461A1 INHIBITORS AGAINST MEMBERS OF THE HEAT SHOCK PROTEIN 90 (hsp90) FAMILY
07/07/2005WO2005061460A1 Compounds, compositions, and methods
07/07/2005WO2005061458A2 Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
07/07/2005WO2005061457A1 Organic compounds
07/07/2005WO2005061455A1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
07/07/2005WO2005061454A1 Agent or method for treatment for severe aphasia in chronic-stage cerebrovascular disorder
07/07/2005WO2005061450A2 Hiv protease inhibiting sulfonamides
07/07/2005WO2005061449A1 Ep2 receptor agonists
07/07/2005WO2005061446A2 Processes for the preparation of aminoalkyl phenylcarbamates
07/07/2005WO2005061440A1 Novel compounds
07/07/2005WO2005061439A1 Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists
07/07/2005WO2005061213A1 A balloon for reforming car steel body
07/07/2005WO2005061007A1 Method of suppressing cancer
07/07/2005WO2005061006A1 Prodrug of anticholinergic agent
07/07/2005WO2005061004A1 Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof
07/07/2005WO2005061003A1 Anti-infective medical device
07/07/2005WO2005061001A1 Method of suppressing cancer
07/07/2005WO2005060981A2 Pharmaceutical compositions
07/07/2005WO2005060979A1 Elemental sulfur as an oral or parentral medical product
07/07/2005WO2005060978A2 Polymetaphosphate based formulations for therapy of microcrystalline arthropathies
07/07/2005WO2005060977A1 Core 2 glcnac-t inhibitors
07/07/2005WO2005060976A2 Use of superoxide dismutase mimetics and reductase glutathione in the form of anticancer drugs
07/07/2005WO2005060975A1 Combination therapies employing a composition comprising a hmg coa reductase inhibitor and a vitamin b6 related compound
07/07/2005WO2005060974A1 Superoxide dismutase mimics for the treatment of optic nerve and retinal damage
07/07/2005WO2005060973A1 Reduction of toxicity of multi-targeting antifolates
07/07/2005WO2005060972A2 Pyrrolo [2,3-d] pyrimidine compounds for treating transplant rejection
07/07/2005WO2005060971A1 Treatment of reflux-related diseases
07/07/2005WO2005060968A1 Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
07/07/2005WO2005060967A1 METHODS OF TREATING ACUTE INFLAMMATION IN ANIMALS WITH p38 MAP KINASE INHIBITORS
07/07/2005WO2005060966A1 Immunostimulant composition comprising at least one toll-like receptor 7 or toll-like receptor 8 agonist and a toll-like receptor 4 agonist
07/07/2005WO2005060965A1 Novel treatment of irritable bowel syndrome i
07/07/2005WO2005060964A1 Novel use of ion channel active compound, meperidine, to mediate process of accelerated wound healing
07/07/2005WO2005060963A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
07/07/2005WO2005060962A1 Use of piketprofen for the preparation of a pharmaceutical composition to treat rosacea
07/07/2005WO2005060961A2 Treatment of transient lower esophageal sphincter relaxations (tlesrs) and gastro-esophageal reflux disease (gerd)
07/07/2005WO2005060960A2 Use of histamine to treat bone disease
07/07/2005WO2005060958A1 (5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes
07/07/2005WO2005060957A1 Formulation of nefopam and its use in the treatment of pain
07/07/2005WO2005060956A1 IMMUNOMODULATORY COMPOUNDS THAT TARGET AND INHIBIT THE pY+3 BINDING SITE OF TYROSENE KINASE p56 LCK SH2 DOMAIN
07/07/2005WO2005060955A1 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and an agent intervening in the prostaglandin metabolism
07/07/2005WO2005060954A1 Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
07/07/2005WO2005060953A1 Use of organic buffering agents to enhance the antimicrobial activity of pharmaceutical compositions
07/07/2005WO2005060952A1 Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite
07/07/2005WO2005060951A2 Anti-neoplastic agents, combination therapies and related methods
07/07/2005WO2005060950A1 Use of idrocilamide for the preparation of a pharmaceutical composition of rosacea
1 ... 4622 4623 4624 4625 4626 4627 4628 4629 4630 4631 4632 4633 4634 4635 4636 4637 4638 4639 4640 4641 4642 ... 7860